🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objectives of the study were: 1. To assess the safety and tolerability...
Status
Completed
Location
Allergy, Asthma and Immunology Associates
Start Date
2009-08-31
Trial ID
NCT00914966
Treatments Being Tested
This is a single arm, open label study of up to 24 high risk prostate cance...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2012-01
Trial ID
NCT01572701
Treatments Being Tested
Study Hypothesis: Preterm infants administered weekly Darbe during the neon...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-09-20
Trial ID
NCT03169881
Treatments Being Tested
The purpose of this study is to examine how effective rituximab or tocilizu...
Status
Active Not Recruiting
Location
Johns Hopkins
Start Date
2020-09-25
Trial ID
NCT04375228
Treatments Being Tested
In this phase II trial, the investigators overarching goal is to demonstrat...
Status
Recruiting
Location
University of Washington
Start Date
2022-11-27
Trial ID
NCT05340465
Treatments Being Tested
To study the effects of Erigeron Injection on human serum VEGF, MMP-9 and E...
Status
Unknown
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01926834
Treatments Being Tested
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
Comparison of the safety and effectiveness of standard drug dosing versus a...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00250432
Treatments Being Tested
To determine the recommended Phase IIa dose (RP2D) of the triplet combinati...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2024-12-31
Trial ID
NCT06683755
Treatments Being Tested